Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Greencoat Renewables inks 10-year power purchase agreement

(Sharecast News) - Greencoat Renewables announced the signing of a significant 10-year power purchase agreement (PPA) on Thursday, with Keppel DC REIT, for its Ballybane Phase 1 wind farm. The AIM-traded company said the wind farm boasted an annual output of 67 GWh of renewable energy.

Under the agreement, Keppel would procure all of the electricity generated in a move aligning with its net zero objectives for 2030.

"We are delighted to announce our first power purchase agreement with Keppel DC REIT," said Greencoat's investment manager, Paul O' Donnell.

"This partnership evidences the significant opportunity for Greencoat Renewables, as the largest operator of wind assets in Ireland, to provide renewable electricity to the growing Irish data centre market.

"In successfully re-contracting Ballybane Phase 1, we have demonstrated our ability to create and sustain long-term value for our investors."

At 0828 BST, shares in Greencoat Renewables were up 1.22% at 0.83p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Distil makes inaugural distillation of Blackwood at Ardgowan
(Sharecast News) - Premium drinks group Distil announced a significant milestone on Tuesday, with the successful inaugural distillation of 'Blackwood' at Ardgowan Distillery.
OptiBiotix Health inks manufacturing deal with KAG Industries
(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its its Indian subsidiary, OptiBiotix Health India (OHI), has entered into a manufacturing agreement with KAG Industries for the supply of 'Slimbiome' products tailored for the Indian market.
Pebble Group maintains consistent trading in year to date
(Sharecast News) - Promotional products commerce and services specialist the Pebble Group said in a trading update on Tuesday that in the year to date, it had maintained a financial performance consistent with the same period in 2023.
Poolbeg agrees 12-month option over potential Behcet's treatment
(Sharecast News) - Poolbeg Pharma announced an exclusive 12-month option agreement with Silk Road Therapeutics on Tuesday, to potentially acquire a novel topical muco-adherent formulation of Pentoxifylline (tPTX).

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.